Relationship between chromogenic factor X and international normalized ratio differs during early warfarin initiation compared with chronic warfarin administration

Blood Coagulation and Fibrinolysis

Volumn 20, Issue 6, 2009, Pages 433-435

  Rosborough, Terry K ^a   Jacobsen, Jennifer M ^a   Shepherd, Michele F ^a  

^a ABBOTT NORTHWESTERN HOSPITAL   (United States)

Author keywords

Argatroban; Direct thrombin inhibitor; Factor X; Heparin induced thrombocytopenia; International normalized ratio; Lepirudin; Lupus anticoagulant; Warfarin

Indexed keywords

BLOOD CLOTTING FACTOR 10; WARFARIN;

ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DRUG MONITORING; FIBRINOLYSIS; HEART ATRIUM FIBRILLATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; OUTPATIENT CARE; PRIORITY JOURNAL; TERTIARY HEALTH CARE;

ADULT; ALGORITHMS; ANTICOAGULANTS; CHROMOGENIC COMPOUNDS; DRUG MONITORING; FACTOR XA; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; INPATIENTS; INTERNATIONAL NORMALIZED RATIO; MALE; OLIGOPEPTIDES; OUTPATIENTS; PROTHROMBIN TIME; TIME FACTORS; WARFARIN;

EID: 69549134255     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBC.0b013e32832ca31f     Document Type: Article

References (5)

1. Moll S, Ortel TL. Monitoring warfarin therapy in patients with lupus anticoagulants. Ann Intern Med 1997; 127:177-185.
2. Rosborough TK, Shepherd MF. Unreliability of international normalized ratio for monitoring warfarin therapy in patients with lupus anticoagulant. Pharmacotherapy 2004; 24:838-842.
3. McGlasson DL, Romick BG, Rubal BJ. Comparison of a chromogenic factor X assay with international normalized ratio for monitoring oral anticoagulation therapy. Blood Coagul Fibrinolysis 2008; 19:513-517.
4. Gosselin RC, Dager WE, King JH, Janatpour K, Mahackian K, Larkin EC, Owings JT. Effect of direct thrombin inhibitors, bivalirudin, lepirudin, and argatroban, on prothrombin time and INR values. Am J Clin Pathol 2004; 121:593-599. (Pubitemid 38392969)
5. Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, Palareti G. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians evidence-based clinical practice guidelines (8th ed.). Chest 2008; 133:160-198. (Pubitemid 351892967)